3.3. Subgroup Analyses
The number of subjects with a clinically relevant decrease >10% of total cholesterol and LDL reduction was compared. The difference was statistically significant in favor of the PG group (with a chi-square of 0.0302); respectively, 17 for PG and 8 for the PL. In addition, the number of subjects showing a BW reduction of ≥5% was significantly higher for the PG group (with a chi-square of 0.0370); respectively, 14 subjects for PG and 6 subjects for the PL.